Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP157690.RAFAjRV4Calxla--rgsFii-SoJhC79jcQcwrOjBxCTZR0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP157690.RAFAjRV4Calxla--rgsFii-SoJhC79jcQcwrOjBxCTZR0130_assertion type Assertion NP157690.RAFAjRV4Calxla--rgsFii-SoJhC79jcQcwrOjBxCTZR0130_head.
- NP157690.RAFAjRV4Calxla--rgsFii-SoJhC79jcQcwrOjBxCTZR0130_assertion description "[The CYP1A1 rs1048943 AG genotype and the combined AG/GG genotypes were associated with increased risk of NHL (OR(AG) = 1.28, 95% CI = 1.07-1.54; OR(AG/GG) = 1.26, 95% CI = 1.06-1.51) and DLBCL (OR(AG) = 1.32, 95% CI = 1.04-1.66; OR(AG/GG) = 1.30, 95% CI = 1.03-1.63), but not T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157690.RAFAjRV4Calxla--rgsFii-SoJhC79jcQcwrOjBxCTZR0130_provenance.
- NP157690.RAFAjRV4Calxla--rgsFii-SoJhC79jcQcwrOjBxCTZR0130_assertion evidence source_evidence_literature NP157690.RAFAjRV4Calxla--rgsFii-SoJhC79jcQcwrOjBxCTZR0130_provenance.
- NP157690.RAFAjRV4Calxla--rgsFii-SoJhC79jcQcwrOjBxCTZR0130_assertion SIO_000772 19899130 NP157690.RAFAjRV4Calxla--rgsFii-SoJhC79jcQcwrOjBxCTZR0130_provenance.
- NP157690.RAFAjRV4Calxla--rgsFii-SoJhC79jcQcwrOjBxCTZR0130_assertion wasDerivedFrom befree-20140225 NP157690.RAFAjRV4Calxla--rgsFii-SoJhC79jcQcwrOjBxCTZR0130_provenance.
- NP157690.RAFAjRV4Calxla--rgsFii-SoJhC79jcQcwrOjBxCTZR0130_assertion wasGeneratedBy ECO_0000203 NP157690.RAFAjRV4Calxla--rgsFii-SoJhC79jcQcwrOjBxCTZR0130_provenance.